| 前收盘价格 | 4.83 |
| 收盘价格 | 5.02 |
| 成交量 | 204,473 |
| 平均成交量 (3个月) | 285,103 |
| 市值 | 90,999,248 |
| 预期市盈率 (P/E Forward) | 10.44 |
| 价格/销量 (P/S) | 0.980 |
| 股市价格/股市净资产 (P/B) | 0.760 |
| 52周波幅 | |
| 利润日期 | 26 Mar 2025 - 31 Mar 2025 |
| 营业毛利率 | -27.41% |
| 营业利益率 (TTM) | -5.03% |
| 稀释每股收益 (EPS TTM) | -1.34 |
| 季度收入增长率 (YOY) | 30.50% |
| 总债务/股东权益 (D/E MRQ) | 31.20% |
| 流动比率 (MRQ) | 3.23 |
| 营业现金流 (OCF TTM) | -1.57 M |
| 杠杆自由现金流 (LFCF TTM) | 8.35 M |
| 资产报酬率 (ROA TTM) | -3.27% |
| 股东权益报酬率 (ROE TTM) | -20.97% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Health Information Services (US) | 混合的 | 看跌 |
| Health Information Services (全球的) | 混合的 | 看跌 | |
| 股票 | OptimizeRx Corporation | 看跌 | 看跌 |
AIStockmoo 评分
1.2
| 分析师共识 | 1.0 |
| 内部交易活动 | 1.5 |
| 价格波动 | 0.5 |
| 技术平均移动指标 | 3.5 |
| 技术振荡指标 | -0.5 |
| 平均 | 1.20 |
|
OptimizeRx Corp is engaged in the healthcare market in the United States. It provides digital health messaging via electronic health records, providing a direct channel for pharmaceutical companies to communicate with healthcare providers and patients. The cloud-based solution supports patient adherence to medications by providing real-time access to financial assistance, prior authorization, education, and clinical information. Its products offering are Financial Messaging, Brand and Clinical Messaging, Brand Support, and Patient Engagement. |
|
| 部门 | Healthcare |
| 行业 | Health Information Services |
| 投资方式 | Small Core |
| 内部持股比例 | 13.29% |
| 机构持股比例 | 68.94% |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 16.00 (Roth MKM, 223.89%) | 购买 |
| 中 | 8.00 (61.94%) | |
| 低 | 5.00 (Barclays, 1.22%) | 保留 |
| 平均值 | 9.19 (86.03%) | |
| 总计 | 6 购买, 2 保留 | |
| 平均价格@调整类型 | 4.39 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| B. Riley Securities | 24 Dec 2024 | 13.00 (163.16%) | 购买 | 4.94 |
| Lake Street | 24 Dec 2024 | 11.00 (122.67%) | 购买 | 4.94 |
| Stephens & Co. | 20 Dec 2024 | 5.50 (11.34%) | 保留 | 4.91 |
| Barclays | 14 Nov 2024 | 5.00 (1.21%) | 保留 | 4.06 |
| JMP Securities | 14 Nov 2024 | 8.00 (61.94%) | 购买 | 4.06 |
| RBC Capital | 14 Nov 2024 | 7.00 (41.70%) | 购买 | 4.06 |
| Roth MKM | 14 Nov 2024 | 16.00 (223.89%) | 购买 | 4.06 |
| Stifel | 14 Nov 2024 | 8.00 (61.94%) | 购买 | 4.06 |
| 名称 | 平均购买 ($) | 平均卖出 ($) | 总净额 | 总净值 ($) |
|---|---|---|---|---|
| FEBBO WILLIAM J | 4.93 | - | 20,000 | 98,600 |
| 累积净数量 | 20,000 | |||
| 累积净值 ($) | 98,600 | |||
| 累积平均购买 ($) | 4.93 | |||
| 累积平均卖出 ($) | - | |||
| 名称 | 持有人 | 日期 | 类型 | 数量 | 价格 | 价值 ($) |
|---|---|---|---|---|---|---|
| FEBBO WILLIAM J | 职员 | 12 Dec 2024 | 买 (+) | 20,000 | 4.93 | 98,600 |
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合